过去一年中添加的文章,按日期排序
您的搜索 - Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators. - 与所有文章均不相符。
建议:
建议: